AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. IPHA
  4. [6-K] Innate Pharma S.A. ADS Current Report (Foreign Issuer)

[6-K] Innate Pharma S.A. ADS Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

Date of report: Monday August 4, 2025
Commission File Number: 001-39084
Innate Pharma S.A.
(Translation of registrant's name into English)

Innate Pharma S.A.
117 Avenue de Luminy—BP 30191
13009 Marseille, France
+ 33 (0) 4 30 30 30
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [ X ]    Form 40-F [ ]



EXHIBIT INDEX

Exhibit    Description

99.1     Press Release dated August 4, 2025



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

INNATE PHARMA S.A.


Date: August 4, 2025    By:    /s/ JONATHAN DICKINSON     Name:    Jonathan Dickinson
Title:    Chief Executive officer


Source:

Stock IPHA logo
Innate Pharma Sa

NASDAQ:IPHA

IPHA Rankings

#4194 Ranked by Market Cap
N/A Ranked by Dividends

IPHA Latest News

Sep 2, 2025
Number of Shares and Voting Rights of Innate Pharma as of September 1, 2025
Aug 4, 2025
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025
Jul 29, 2025
Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference
Jul 4, 2025
Number of Shares and Voting Rights of Innate Pharma as of July 3, 2025
Jun 17, 2025
Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences

IPHA Latest SEC Filings

Sep 2, 2025
[6-K] Innate Pharma S.A. ADS Current Report (Foreign Issuer)
Jul 29, 2025
[6-K] Innate Pharma S.A. ADS Current Report (Foreign Issuer)
Jul 7, 2025
[6-K] Innate Pharma S.A. ADS Current Report (Foreign Issuer)

IPHA Stock Data

199.09M
92.18M
0.17%
0.08%
Biotechnology
Healthcare
France
Marseille